These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3886753)

  • 1. An "account" of digitalis and atrial fibrillation.
    Meijler FL
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):60A-68A. PubMed ID: 3886753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome.
    Milstein S; Klein GJ; Rattes MF; Sharma AD; Yee R
    J Am Coll Cardiol; 1987 Dec; 10(6):1244-8. PubMed ID: 3680792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of atrial fibrillation and atrioventricular conduction (including Wolff-Parkinson-White syndrome) in sudden death.
    Meijler FL; van der Tweel I; Herbschleb JN; Hauer RN; Robles de Medina EO
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):17B-22B. PubMed ID: 3998333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of the ventricular rate during atrial fibrillation.
    Toivonen L; Kadish A; Kou W; Morady F
    J Am Coll Cardiol; 1990 Nov; 16(5):1194-200. PubMed ID: 2229766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wolff-Parkinson-White syndrome and atrial fibrillation. Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation.
    Wellens HJ; Durrer D
    Am J Cardiol; 1974 Dec; 34(7):777-82. PubMed ID: 4432808
    [No Abstract]   [Full Text] [Related]  

  • 6. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.
    Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Yee R
    Anesthesiology; 1995 Apr; 82(4):888-95. PubMed ID: 7717560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AV nodal function during atrial fibrillation: the role of electrotonic modulation of propagation.
    Meijler FL; Jalife J; Beaumont J; Vaidya D
    J Cardiovasc Electrophysiol; 1996 Sep; 7(9):843-61. PubMed ID: 8884513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
    Morady F; DiCarlo LA; Baerman JM; De Buitleir M
    Pacing Clin Electrophysiol; 1987 May; 10(3 Pt 1):492-6. PubMed ID: 2439997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diltiazem on concealed atrioventricular nodal conduction in relation to ventricular response during atrial fibrillation in anesthetized dogs.
    Fujiki A; Mizumaki K; Tani M
    Am Heart J; 1993 May; 125(5 Pt 1):1284-9. PubMed ID: 8480579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-excited RR intervals during atrial fibrillation in the Wolff-Parkinson-White syndrome: influence of the atrioventricular node refractory period.
    Fujimura O; Kuo CS; Smith BA
    J Am Coll Cardiol; 1991 Dec; 18(7):1722-6. PubMed ID: 1960320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms determining the ventricular rate in wolff-parkinson-white arrhythmias.
    Castellanos A; Levy S; Befeler B; Myerburg RJ
    Adv Cardiol; 1975; 14():221-32. PubMed ID: 1136885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-entry--an important mechanism of cardiac arrhythmias.
    Kastor JA; Goldreyer BN; Moore EN; Spear JF
    Cardiovasc Clin; 1974; 6(1):111-35. PubMed ID: 4140023
    [No Abstract]   [Full Text] [Related]  

  • 13. Concealed conduction.
    Childers R
    Med Clin North Am; 1976 Jan; 60(1):149-73. PubMed ID: 1246167
    [No Abstract]   [Full Text] [Related]  

  • 14. Dissimilar atrial rhythms in a patient with the Wolff-Parkinson-White syndrome.
    Genetos BC; Gaum WE; Etharrar V; Zipes DP
    Chest; 1977 Nov; 72(5):663-6. PubMed ID: 913153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of atrioventricular conduction by ablation of the "slow" atrioventricular node pathway in patients with drug-refractory atrial fibrillation or flutter.
    Della Bella P; Carbucicchio C; Tondo C; Riva S
    J Am Coll Cardiol; 1995 Jan; 25(1):39-46. PubMed ID: 7798523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the atrioventricular node in atrial fibrillation: what have we learned from radiofrequency catheter modification of the atrioventricular junction in patients with refractory atrial fibrillation?
    Aliot E; Sadoul N; de Chillou C
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S132-8. PubMed ID: 9727688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wolff-Parkinson-White syndrome in children: electrophysiologic and pharmacologic characteristics.
    Gillette PC; Garson A; Kugler JD
    Circulation; 1979 Dec; 60(7):1487-95. PubMed ID: 498476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological evaluation of the sinus node and the cardiac conduction system following the maze procedure for atrial fibrillation.
    Albåge A; Lindblom D; Insulander P; Kennebäck G
    Pacing Clin Electrophysiol; 2004 Feb; 27(2):194-203. PubMed ID: 14764170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular response to atrial fibrillation: role of atrioventricular conduction pathways.
    Kirsh JA; Sahakian AV; Baerman JM; Swiryn S
    J Am Coll Cardiol; 1988 Nov; 12(5):1265-72. PubMed ID: 3170970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation.
    Verrier RL; Sobrado MF; Pagotto VP; Kanas AF; Machado AD; Varone BB; Sobrado LF; Nearing BD; Zeng D; Belardinelli L
    Heart Rhythm; 2013 Nov; 10(11):1692-7. PubMed ID: 23933296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.